Literature DB >> 11073862

Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptors.

M Cattaneo1, A Lecchi, R Lombardi, C Gachet, M L Zighetti.   

Abstract

Two unrelated patients with a congenital bleeding diathesis associated with a severe defect of the platelet ADP receptor coupled to adenylate cyclase (P2(CYC)) have been described so far. In one of them, platelet secretion was shown to be abnormal. We recently showed that platelets with the primary secretion defect (PSD; characterized by abnormal secretion but normal granule stores, thromboxane A(2) production, and ADP-induced primary wave of aggregation) have a moderate defect of P2(CYC). Therefore, the interaction of ADP with the full complement of its receptors seems to be essential for normal platelet secretion, and PSD patients may be heterozygotes for the congenital severe defect of P2(CYC). In this study, we describe 2 new related patients with a severe defect of P2(CYC) and the son of one of them, who is to be considered an obligate heterozygote for the defect. The 2 patients with the severe defect had lifelong histories of abnormal bleeding, prolonged bleeding times, abnormalities of platelet aggregation and secretion, lack of inhibition of adenylate cyclase by ADP, and a deficiency of platelet-binding sites for [(33)P]2 MeS-ADP (240 and 225 sites per platelet; normal range, 530 to 1102). The son of one of them had a mildly prolonged bleeding time and abnormalities of platelet aggregation and secretion similar to those found in patients with PSD. In addition, his platelets showed a moderate defect of binding sites for [(33)P]2 MeS-ADP (430 sites per platelet) and of adenylate cyclase inhibition by ADP. This study of a family with the platelet disorder characterized by a defect of the platelet P2(CYC) receptor supports our hypothesis that the full complement of the platelet ADP receptors is essential for normal platelet secretion and that some patients with the common, ill-defined diagnosis of PSD are actually heterozygous for the defect.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073862     DOI: 10.1161/01.atv.20.11.e101

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  28 in total

Review 1.  Central role of the P2Y12 receptor in platelet activation.

Authors:  Robert T Dorsam; Satya P Kunapuli
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 2.  P2Y(12) receptors in platelets and other hematopoietic and non-hematopoietic cells.

Authors:  Christian Gachet
Journal:  Purinergic Signal       Date:  2012-04-11       Impact factor: 3.765

Review 3.  International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy.

Authors:  Maria P Abbracchio; Geoffrey Burnstock; Jean-Marie Boeynaems; Eric A Barnard; José L Boyer; Charles Kennedy; Gillian E Knight; Marta Fumagalli; Christian Gachet; Kenneth A Jacobson; Gary A Weisman
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

Review 4.  P2Y12 receptor: platelet thrombus formation and medical interventions.

Authors:  Fatemeh Moheimani; Denise E Jackson
Journal:  Int J Hematol       Date:  2012-10-01       Impact factor: 2.490

Review 5.  The role of P2Y₁₂ receptor and activated platelets during inflammation.

Authors:  Elisabetta Liverani; Laurie E Kilpatrick; Alexander Y Tsygankov; Satya P Kunapuli
Journal:  Curr Drug Targets       Date:  2014       Impact factor: 3.465

Review 6.  Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties.

Authors:  Nicola Ferri; Alberto Corsini; Stefano Bellosta
Journal:  Drugs       Date:  2013-10       Impact factor: 9.546

7.  Molecular defects of the platelet P2 receptors.

Authors:  Marco Cattaneo
Journal:  Purinergic Signal       Date:  2011-01-29       Impact factor: 3.765

Review 8.  Inherited dysfunctional platelet P2Y12 receptor mutations associated with bleeding disorders.

Authors:  Anna Lecchi; Eti A Femia; Silvia Paoletta; Arnaud Dupuis; Philippe Ohlmann; Christian Gachet; Kenneth A Jacobson; Katharina Machura; Gian M Podda; Barbara Zieger; Marco Cattaneo
Journal:  Hamostaseologie       Date:  2016-08-04       Impact factor: 1.778

9.  Identification of determinants required for agonistic and inverse agonistic ligand properties at the ADP receptor P2Y12.

Authors:  Philipp Schmidt; Lars Ritscher; Elizabeth N Dong; Thomas Hermsdorf; Maxi Cöster; Doreen Wittkopf; Jens Meiler; Torsten Schöneberg
Journal:  Mol Pharmacol       Date:  2012-10-23       Impact factor: 4.436

10.  Molecular bases of defective signal transduction in the platelet P2Y12 receptor of a patient with congenital bleeding.

Authors:  Marco Cattaneo; Maddalena L Zighetti; Rossana Lombardi; Constantino Martinez; Anna Lecchi; Pamela B Conley; Jerry Ware; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.